Carey, Aaron Charles David – Trademark Portfolio
Entity Type: 01
Carey, Aaron Charles David holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 3 (Cosmetics & Cleaning) — 1 filings in this category. The portfolio also extends into Class 4 (Lubricants & Fuels) across 3 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include CAREYOSITY and APOTHECAREY. The owner is based in Olympia, WA.
2103 Harrison Ave NW STE 2 PMB 1024
81 SE Highland Dr. Shelton WA 98584
Olympia, WA 98502
Showing of trademarks Trademarks
Trademark Classifications
Carey, Aaron Charles David's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring
Industrial oils and greases; lubricants; dust absorbing, wetting and binding compositions
Frequently Asked Questions
How many trademarks does Carey, Aaron Charles David have?
Carey, Aaron Charles David has 2 U.S. trademarks filed with the USPTO. Of these, 2 registered.
What trademark classes does Carey, Aaron Charles David file in?
Carey, Aaron Charles David files trademarks across 3 Nice Classification classes. The most active classes are Class 3 (Cosmetics & Cleaning), Class 4 (Lubricants & Fuels), Class 40 (Treatment & Processing). Class 3 covers bleaching preparations and other substances for laundry use; cleaning, polishing, scouring.
What are Carey, Aaron Charles David's most well-known trademarks?
Carey, Aaron Charles David's registered trademark portfolio includes well-known marks such as CAREYOSITY and APOTHECAREY. These are among 2 currently registered trademarks in the portfolio.
What is Carey, Aaron Charles David's trademark registration success rate?
Carey, Aaron Charles David has a 100% trademark registration rate, with 2 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.